- Salbair I Neb 1.25 mg Transpules 2.5 ml effectively alleviates symptoms of chronic obstructive pulmonary disease (COPD).
- This formulation helps in relaxing airway muscles, making breathing easier.
- Salbair I Neb 1.25 mg Transpules 2.5 ml is beneficial for patients experiencing wheezing and shortness of breath.
- It aids in reducing the frequency of COPD exacerbations.
- Salbair I Neb 1.25 mg Transpules 2.5 ml can improve overall lung function.
- This medication is suitable for patients who struggle with traditional inhalers.
- Salbair I Neb 1.25 mg Transpules 2.5 ml provides rapid relief from acute respiratory distress.
- It is designed for easy administration via nebulization.
- Salbair I Neb 1.25 mg Transpules 2.5 ml supports better oxygenation in patients with compromised lung function.
- This therapy can enhance the quality of life for individuals with chronic respiratory conditions.
- Salbair I Neb 1.25 mg Transpules 2.5 ml is often recommended as part of a comprehensive COPD management plan.
- It helps in minimizing the need for rescue inhalers during acute episodes.
Salbair I Neb 1.25 mg Transpules 2.5 ml
Prescription Required
Compositions : Levosalbutamol 1.25mg + Ipratropium Bromide 500mcg
₹21.85
(Incl. GST)
MRP :
(Incl. GST)
MRP :
In stock
Delivery within 2 to 7 Working Days
Manufacture/Marketer: Lupin Limited
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Description
Salbair I Neb 1.25 mg Transpules 2.5 ml is a specialized inhalation solution designed for patients suffering from chronic obstructive pulmonary disease (COPD). This formulation combines two active ingredients: Levosalbutamol and Ipratropium, which work synergistically to provide relief from respiratory distress. Salbair I Neb 1.25 mg Transpules 2.5 ml is classified as a bronchodilator and an anticholinergic agent, making it effective in relaxing the muscles of the airways and widening them, thereby facilitating easier breathing. The primary purpose of Salbair I Neb 1.25 mg Transpules 2.5 ml is to manage symptoms associated with COPD, such as wheezing, shortness of breath, and chest tightness. By utilizing this medication, patients can experience improved lung function and enhanced quality of life. Salbair I Neb 1.25 mg Transpules 2.5 ml is administered via nebulization, ensuring that the medication reaches the lungs directly for optimal efficacy. This method of delivery is particularly beneficial for individuals who may have difficulty using traditional inhalers. The key composition of Salbair I Neb 1.25 mg Transpules 2.5 ml includes Levosalbutamol, which acts as a bronchodilator, and Ipratropium, which serves as an anticholinergic agent. Together, these components create a powerful therapeutic category aimed at alleviating the symptoms of COPD. Salbair I Neb 1.25 mg Transpules 2.5 ml not only helps in managing acute symptoms but also plays a crucial role in preventing exacerbations of the condition, making it an essential part of COPD management plans.
Product Details
Uses & Benefits
How Salbair I Neb 1.25 mg Transpules 2.5 ml works
Salbair I Neb 1.25 mg Transpules 2.5 ml works through a combination of two active ingredients: Levosalbutamol and Ipratropium. These components act together to provide effective relief from respiratory symptoms associated with COPD.
Salbair I Neb 1.25 mg Transpules 2.5 ml works through a combination of two active ingredients: Levosalbutamol and Ipratropium. These components act together to provide effective relief from respiratory symptoms associated with COPD.
- Levosalbutamol is a selective beta-2 adrenergic agonist that relaxes bronchial smooth muscles, leading to bronchodilation.
- Ipratropium is an anticholinergic agent that inhibits bronchoconstriction by blocking acetylcholine receptors in the airways.
- Together, they widen the airways and improve airflow to the lungs.
- Salbair I Neb 1.25 mg Transpules 2.5 ml helps reduce airway inflammation and mucus production.
- This combination therapy enhances lung function and decreases the severity of COPD symptoms.
- The formulation allows for direct delivery to the lungs via nebulization, maximizing therapeutic effects.
How to use Salbair I Neb 1.25 mg Transpules 2.5 ml
- Salbair I Neb 1.25 mg Transpules 2.5 ml should be used only via nebulization; do not swallow the solution.
- The recommended dosage is typically one vial (2.5 ml) per administration.
- Use Salbair I Neb 1.25 mg Transpules 2.5 ml as prescribed by your healthcare provider, usually two to four times daily.
- Ensure that the nebulizer is clean and functioning properly before use.
- Inhale the mist slowly and deeply until the solution is fully consumed.
- Duration of treatment with Salbair I Neb 1.25 mg Transpules 2.5 ml should be determined by your doctor based on individual needs.
- Follow any special instructions provided by your healthcare professional regarding usage frequency and timing.
- Consult your doctor if symptoms do not improve or worsen after using Salbair I Neb 1.25 mg Transpules 2.5 ml.
Lifestyle Advice
- Maintain good hydration to help alleviate dry mouth associated with Salbair I Neb 1.25 mg Transpules 2.5 ml use.
- Avoid exposure to allergens and irritants that may worsen respiratory symptoms.
- Incorporate regular physical activity as tolerated to improve lung function.
- Practice good oral hygiene to prevent fungal infections in the mouth and throat after using this medication.
- Avoid smoking and secondhand smoke exposure to enhance treatment effectiveness.
Safety Advice
Side Effects
Side Effects
- Common side effects of Salbair I Neb 1.25 mg Transpules 2.5 ml include dry mouth and cough.
- Patients may experience headaches or dizziness after using this medication.
- Some individuals report nausea or vomiting as potential side effects.
- Local reactions such as throat irritation may occur but usually resolve quickly.
- Serious side effects are rare but may include wheezing or tightening of the airways (bronchospasm).
- If severe side effects occur, seek immediate medical attention.
- Consult your doctor if side effects persist or cause concern.
Precautions and Warnings
Precautions & Warnings
- Salbair I Neb 1.25 mg Transpules 2.5 ml should not be used by individuals with a known hypersensitivity to Levosalbutamol or Ipratropium.
- Patients with certain heart conditions should consult their doctor before using this medication.
- Avoid alcohol consumption while using Salbair I Neb 1.25 mg Transpules 2.5 ml as it may exacerbate side effects.
- Pregnant or breastfeeding women should discuss potential risks with their healthcare provider before use.
- Monitor blood potassium levels regularly if using Salbair I Neb 1.25 mg Transpules 2.5 ml, especially in patients with hypoxia.
- Driving or operating heavy machinery should be avoided if dizziness occurs after using this medication.
- Consult a healthcare professional if experiencing any unusual symptoms after administration.
FAQs
1. What is Salbair I Neb 1.25 mg Transpules 2.5 ml used for?
Salbair I Neb 1.25 mg Transpules 2.5 ml is primarily used for treating chronic obstructive pulmonary disease (COPD), helping to alleviate symptoms like wheezing and shortness of breath.
2. How should Salbair I Neb 1.25 mg Transpules 2.5 ml be administered?
This medication should be administered via nebulization only, ensuring proper inhalation technique for maximum effectiveness.
3. Are there any common side effects associated with Salbair I Neb 1.25 mg Transpules 2.5 ml?
Common side effects include dry mouth, cough, headache, and dizziness; most are mild and resolve on their own.
4. Can anyone use Salbair I Neb 1.25 mg Transpules 2.5 ml?
Individuals with hypersensitivity to its components or certain heart conditions should avoid using this medication; consult a healthcare provider for personalized advice.
5. What precautions should be taken while using Salbair I Neb 1.25 mg Transpules 2.5 ml?
Patients should monitor their potassium levels regularly and avoid alcohol; pregnant or breastfeeding women should consult their doctor before use.
6. How does Salbair I Neb 1.25 mg Transpules 2.5 ml work?
The medication combines Levosalbutamol, a bronchodilator, and Ipratropium, an anticholinergic, which work together to relax airway muscles and improve breathing.
Salbair I Neb 1.25 mg Transpules 2.5 ml is primarily used for treating chronic obstructive pulmonary disease (COPD), helping to alleviate symptoms like wheezing and shortness of breath.
2. How should Salbair I Neb 1.25 mg Transpules 2.5 ml be administered?
This medication should be administered via nebulization only, ensuring proper inhalation technique for maximum effectiveness.
3. Are there any common side effects associated with Salbair I Neb 1.25 mg Transpules 2.5 ml?
Common side effects include dry mouth, cough, headache, and dizziness; most are mild and resolve on their own.
4. Can anyone use Salbair I Neb 1.25 mg Transpules 2.5 ml?
Individuals with hypersensitivity to its components or certain heart conditions should avoid using this medication; consult a healthcare provider for personalized advice.
5. What precautions should be taken while using Salbair I Neb 1.25 mg Transpules 2.5 ml?
Patients should monitor their potassium levels regularly and avoid alcohol; pregnant or breastfeeding women should consult their doctor before use.
6. How does Salbair I Neb 1.25 mg Transpules 2.5 ml work?
The medication combines Levosalbutamol, a bronchodilator, and Ipratropium, an anticholinergic, which work together to relax airway muscles and improve breathing.
Instructions
Directions for Use
Use only as prescribed by your physician.
Storage and Disposal
Please refer to the product label for storage information.
More Information
| SKU | 193055 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Lupin Limited |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage | Please refer to the product label for storage information. |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Salbair I Neb 1.25 mg Transpules 2.5 ml is a specialized inhalation solution designed for patients suffering from chronic obstructive pulmonary disease (COPD). This formulation combines two active ingredients: Levosalbutamol and Ipratropium, which work synergistically to provide relief from respiratory distress. Salbair I Neb 1.25 mg Transpules 2.5 ml is classified as a bronchodilator and an anticholinergic agent, making it effective in relaxing the muscles of the airways and widening them, thereby facilitating easier breathing. The primary purpose of Salbair I Neb 1.25 mg Transpules 2.5 ml is to manage symptoms associated with COPD, such as wheezing, shortness of breath, and chest tightness. By utilizing this medication, patients can experience improved lung function and enhanced quality of life. Salbair I Neb 1.25 mg Transpules 2.5 ml is administered via nebulization, ensuring that the medication reaches the lungs directly for optimal efficacy. This method of delivery is particularly beneficial for individuals who may have difficulty using traditional inhalers. The key composition of Salbair I Neb 1.25 mg Transpules 2.5 ml includes Levosalbutamol, which acts as a bronchodilator, and Ipratropium, which serves as an anticholinergic agent. Together, these components create a powerful therapeutic category aimed at alleviating the symptoms of COPD. Salbair I Neb 1.25 mg Transpules 2.5 ml not only helps in managing acute symptoms but also plays a crucial role in preventing exacerbations of the condition, making it an essential part of COPD management plans.
Uses & Benefits
- Salbair I Neb 1.25 mg Transpules 2.5 ml effectively alleviates symptoms of chronic obstructive pulmonary disease (COPD).
- This formulation helps in relaxing airway muscles, making breathing easier.
- Salbair I Neb 1.25 mg Transpules 2.5 ml is beneficial for patients experiencing wheezing and shortness of breath.
- It aids in reducing the frequency of COPD exacerbations.
- Salbair I Neb 1.25 mg Transpules 2.5 ml can improve overall lung function.
- This medication is suitable for patients who struggle with traditional inhalers.
- Salbair I Neb 1.25 mg Transpules 2.5 ml provides rapid relief from acute respiratory distress.
- It is designed for easy administration via nebulization.
- Salbair I Neb 1.25 mg Transpules 2.5 ml supports better oxygenation in patients with compromised lung function.
- This therapy can enhance the quality of life for individuals with chronic respiratory conditions.
- Salbair I Neb 1.25 mg Transpules 2.5 ml is often recommended as part of a comprehensive COPD management plan.
- It helps in minimizing the need for rescue inhalers during acute episodes.
How Salbair I Neb 1.25 mg Transpules 2.5 ml works
Salbair I Neb 1.25 mg Transpules 2.5 ml works through a combination of two active ingredients: Levosalbutamol and Ipratropium. These components act together to provide effective relief from respiratory symptoms associated with COPD.
Salbair I Neb 1.25 mg Transpules 2.5 ml works through a combination of two active ingredients: Levosalbutamol and Ipratropium. These components act together to provide effective relief from respiratory symptoms associated with COPD.
- Levosalbutamol is a selective beta-2 adrenergic agonist that relaxes bronchial smooth muscles, leading to bronchodilation.
- Ipratropium is an anticholinergic agent that inhibits bronchoconstriction by blocking acetylcholine receptors in the airways.
- Together, they widen the airways and improve airflow to the lungs.
- Salbair I Neb 1.25 mg Transpules 2.5 ml helps reduce airway inflammation and mucus production.
- This combination therapy enhances lung function and decreases the severity of COPD symptoms.
- The formulation allows for direct delivery to the lungs via nebulization, maximizing therapeutic effects.
How to use Salbair I Neb 1.25 mg Transpules 2.5 ml
- Salbair I Neb 1.25 mg Transpules 2.5 ml should be used only via nebulization; do not swallow the solution.
- The recommended dosage is typically one vial (2.5 ml) per administration.
- Use Salbair I Neb 1.25 mg Transpules 2.5 ml as prescribed by your healthcare provider, usually two to four times daily.
- Ensure that the nebulizer is clean and functioning properly before use.
- Inhale the mist slowly and deeply until the solution is fully consumed.
- Duration of treatment with Salbair I Neb 1.25 mg Transpules 2.5 ml should be determined by your doctor based on individual needs.
- Follow any special instructions provided by your healthcare professional regarding usage frequency and timing.
- Consult your doctor if symptoms do not improve or worsen after using Salbair I Neb 1.25 mg Transpules 2.5 ml.
Lifestyle Advice
- Maintain good hydration to help alleviate dry mouth associated with Salbair I Neb 1.25 mg Transpules 2.5 ml use.
- Avoid exposure to allergens and irritants that may worsen respiratory symptoms.
- Incorporate regular physical activity as tolerated to improve lung function.
- Practice good oral hygiene to prevent fungal infections in the mouth and throat after using this medication.
- Avoid smoking and secondhand smoke exposure to enhance treatment effectiveness.
Side Effects
Side Effects
- Common side effects of Salbair I Neb 1.25 mg Transpules 2.5 ml include dry mouth and cough.
- Patients may experience headaches or dizziness after using this medication.
- Some individuals report nausea or vomiting as potential side effects.
- Local reactions such as throat irritation may occur but usually resolve quickly.
- Serious side effects are rare but may include wheezing or tightening of the airways (bronchospasm).
- If severe side effects occur, seek immediate medical attention.
- Consult your doctor if side effects persist or cause concern.
Precautions and Warnings
Precautions & Warnings
- Salbair I Neb 1.25 mg Transpules 2.5 ml should not be used by individuals with a known hypersensitivity to Levosalbutamol or Ipratropium.
- Patients with certain heart conditions should consult their doctor before using this medication.
- Avoid alcohol consumption while using Salbair I Neb 1.25 mg Transpules 2.5 ml as it may exacerbate side effects.
- Pregnant or breastfeeding women should discuss potential risks with their healthcare provider before use.
- Monitor blood potassium levels regularly if using Salbair I Neb 1.25 mg Transpules 2.5 ml, especially in patients with hypoxia.
- Driving or operating heavy machinery should be avoided if dizziness occurs after using this medication.
- Consult a healthcare professional if experiencing any unusual symptoms after administration.
1. What is Salbair I Neb 1.25 mg Transpules 2.5 ml used for?
Salbair I Neb 1.25 mg Transpules 2.5 ml is primarily used for treating chronic obstructive pulmonary disease (COPD), helping to alleviate symptoms like wheezing and shortness of breath.
2. How should Salbair I Neb 1.25 mg Transpules 2.5 ml be administered?
This medication should be administered via nebulization only, ensuring proper inhalation technique for maximum effectiveness.
3. Are there any common side effects associated with Salbair I Neb 1.25 mg Transpules 2.5 ml?
Common side effects include dry mouth, cough, headache, and dizziness; most are mild and resolve on their own.
4. Can anyone use Salbair I Neb 1.25 mg Transpules 2.5 ml?
Individuals with hypersensitivity to its components or certain heart conditions should avoid using this medication; consult a healthcare provider for personalized advice.
5. What precautions should be taken while using Salbair I Neb 1.25 mg Transpules 2.5 ml?
Patients should monitor their potassium levels regularly and avoid alcohol; pregnant or breastfeeding women should consult their doctor before use.
6. How does Salbair I Neb 1.25 mg Transpules 2.5 ml work?
The medication combines Levosalbutamol, a bronchodilator, and Ipratropium, an anticholinergic, which work together to relax airway muscles and improve breathing.
Salbair I Neb 1.25 mg Transpules 2.5 ml is primarily used for treating chronic obstructive pulmonary disease (COPD), helping to alleviate symptoms like wheezing and shortness of breath.
2. How should Salbair I Neb 1.25 mg Transpules 2.5 ml be administered?
This medication should be administered via nebulization only, ensuring proper inhalation technique for maximum effectiveness.
3. Are there any common side effects associated with Salbair I Neb 1.25 mg Transpules 2.5 ml?
Common side effects include dry mouth, cough, headache, and dizziness; most are mild and resolve on their own.
4. Can anyone use Salbair I Neb 1.25 mg Transpules 2.5 ml?
Individuals with hypersensitivity to its components or certain heart conditions should avoid using this medication; consult a healthcare provider for personalized advice.
5. What precautions should be taken while using Salbair I Neb 1.25 mg Transpules 2.5 ml?
Patients should monitor their potassium levels regularly and avoid alcohol; pregnant or breastfeeding women should consult their doctor before use.
6. How does Salbair I Neb 1.25 mg Transpules 2.5 ml work?
The medication combines Levosalbutamol, a bronchodilator, and Ipratropium, an anticholinergic, which work together to relax airway muscles and improve breathing.
Directions for Use
Use only as prescribed by your physician.
Storage and Disposal
Please refer to the product label for storage information.
| SKU | 193055 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Lupin Limited |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage | Please refer to the product label for storage information. |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Customer Reviews
No reviews yet
Be the first to share your thoughts. Honest feedback helps other shoppers and us serve you better.
Write Your Own Review
Only registered users can write reviews. Please Sign in or create an account